Pfizer, BioNTech to accelerate offer of COVID vaccine to placebo volunteers
Pfizer and its partner BioNTech have plans to begin offering their COVID-19 vaccine to clinical trial volunteers who received placebo by March 1, several months earlier than initially planned, STAT reported.
The FDA and its advisers had pushed hard for volunteers to remain on placebo as long as possible to gather more safety and efficacy data about the vaccines, while the companies argued that volunteers should receive the vaccines sooner for both ethical and practical reasons.
-ABC News' Eric M. Strauss